EP4292602A1 - INTRANASAL ADMINISTRATION OF A POLYCLONAL BLOOD DERIVATIVE DIRECTED AGAINST A PATHOGEN AGENT FOR THE PREVENTION AND/OR TREATMENT OF AN AIRBORNE DISEASE